外裂性结合剂:增强抗体与药物结合物的稳定性和治疗效果
Tomohiro Watanabe1, Naoko Arashida, Tomohiro Fujii1
1Ajinomoto Co., Inc., 1-1, Suzuki-Cho, Kawasaki-Ku, Kawasaki-Shi, Kanagawa 210-8681, Japan.
Journal of medicinal chemistry
|October 16, 2024
概括
这项研究引入了一种外链,通过增强稳定性和瘤有效载荷释放来改善抗体-药物合物 (ADC). 新的链接器设计克服了传统的氨酸-氨酸链接器的局限性,以获得更好的体内性能.
科学领域:
- 生物结合化学 生物结合化学
- 药物输送系统 药物输送系统
- 抗体 - 药物结合剂 抗体-药物结合剂
背景情况:
- 抗体-药物合物 (ADC) 通过化学链接器将细胞毒性有效载荷与单克隆抗体联系起来.
- 传统的氨酸-氨酸 (Val-Cit) 结合剂面临着诸如聚合,有限的药物抗体比率 (DAR) 和过早的有效载荷释放等挑战.
研究的目的:
- 为ADCs制定一个改进的链接器策略,以提高循环稳定性和瘤特异性有效载荷释放.
- 解决与传统的Val-Cit连接器相关的局限性.
主要方法:
- 引入一个外链接器方法,重新定位可切割的链接器.
- 在链接器设计中加入水友性谷氨酸.
- 在体外和体内对外链接器ADC的评估.
主要成果:
- 埃克索林克的ADC显示,有效载荷提前释放减少,DAR增加.
- 避免了显著的聚合,即使在疏水的有效载荷.
- 稳定的有效载荷的附着被观察到在存在的酶,如氧化酶和人类中性粒细胞弹性酶.
结论:
- 外链接器方法为ADC开发提供了与传统线性链接器相比的进步.
- 这种新的设计改善了ADC的体内特征,并由于稳定的有效载荷附着,提出了有利的安全特征.
更多相关视频
08:47Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates
Published on: March 6, 2019
9.4K
10:35Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo
Published on: February 5, 2021
3.4K
相关概念视频
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Antibody Actions
1.1K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.1K
Phase II Conjugation Reactions: Overview
167
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
167
Drug-Receptor Bonds
2.7K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
2.7K
Antibody Structure
59.4K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
59.4K
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
